A peptide certificate of analysis (COA) reports purity for the peptide salt, not the bare peptide chain. Part of that mass is the counter-ion, the charged molecule that pairs with the peptide during manufacturing. Which counter-ion it is changes how much actual peptide you get, so it matters when you compare products or work out net content.
What is a salt form?
Peptides are synthesized as charged molecules. During and after solid-phase peptide synthesis (SPPS), the free amino and guanidinium groups on the peptide backbone carry positive charges, and those have to be balanced by a negatively charged counter-ion. The result is a peptide salt: the peptide paired with an anionic species. Two counter-ions show up most often in research-grade peptides. One is acetate (CH₃COO⁻). The other is trifluoroacetate (CF₃COO⁻), usually abbreviated TFA.
The salt form leaves the amino acid sequence and primary structure untouched. What it changes is the molecular weight of the compound as you weigh it, and so the actual moles of peptide in a given mass of product.
Acetate vs. trifluoroacetate
TFA gets into the product during synthesis and purification. Trifluoroacetic acid cleaves the assembled chain from the resin and strips off side-chain protecting groups, and it's a common additive in the reversed-phase HPLC buffers used to purify peptides. Residual TFA ions stay attached to the peptide's basic sites. The trifluoroacetate counter-ion weighs roughly 114 g/mol, well above acetate's roughly 59 g/mol, so a larger share of the weighed mass is counter-ion instead of peptide. For longer or more basic peptides, the ones with several lysine, arginine, or histidine residues, TFA can account for a real fraction of total mass.
Acetate counter-ions are put in by exchanging the crude or purified peptide with acetic acid or ammonium acetate, usually through a salt-exchange or ion-exchange step. Acetate salts are lighter, and they're often preferred for biological assay work. Part of the reason: trifluoroacetate has been reported in the research literature to inhibit cell proliferation and to be cytotoxic to several cell types in a dose-dependent way. Those effects go back at least to a 1999 study in the American Journal of Physiology — Endocrinology and Metabolism showing that trifluoroacetate inhibited proliferation of osteoblasts and chondrocytes.
| Property | Acetate form | TFA form |
|---|---|---|
| Counter-ion formula | CH₃COO⁻ | CF₃COO⁻ |
| Approximate MW of counter-ion | ~59 g/mol | ~114 g/mol |
| Introduced by | Post-synthesis salt/ion exchange | SPPS cleavage and HPLC purification |
| Net peptide content (relative) | Higher per gram weighed | Lower per gram weighed |
| Common concern in research | Generally less noted | Reported cytotoxicity in cell assays |
Why net peptide content matters
A COA reporting "98% purity by HPLC" is describing the ratio of the target peptide peak to all the other UV-absorbing peaks in the chromatogram. Counter-ions like TFA and acetate are essentially UV-transparent at the wavelengths used for peptide analysis, around 214–220 nm, so they don't register as distinct peaks. HPLC purity tells you almost nothing about whether they're there or how much mass they take up. Two products with identical HPLC purity can deliver different moles of active peptide per milligram if one is the acetate salt and the other the TFA salt.
Net peptide content is a separate number. It's typically determined by quantitative amino acid analysis or nitrogen (Kjeldahl/Dumas) determination, and it reflects the actual peptide mass fraction once you account for counter-ions, water, and residual solvents. As manufacturers such as AmbioPharm describe it, a peptide reported at high HPLC purity can still have a net peptide content well below 90% once counter-ions and water are subtracted out. Research-oriented buyers often look for this figure next to HPLC purity because it gives a fuller picture of what's actually in the vial.
Independent testing fits in here too. Labs such as Janoshik Analytical publish COAs reporting HPLC purity and mass-spectrometry identity confirmation; net peptide content via amino acid analysis is a distinct test, and it isn't always included. Aggregators such as Peptigrity don't test samples themselves. They collect third-party lab results and buyer reviews into shop ratings, and their educational material discusses why net peptide content can sit well below HPLC purity.
Pharmacopeial monographs and guidance from bodies such as the USP and the European Medicines Agency describe content and counter-ion testing methods for approved peptide drug substances. Most peptides sold through online vendors aren't approved drug substances. They're labeled for research use only and not approved for human consumption, and they sit outside any regulatory approval framework. For those, independent third-party COAs are the main way a buyer can assess salt form and net content.
Sources
- Bachem — Quality Control of Amino Acids and Peptides
- AmbioPharm — How is Theoretical Net Peptide Content Calculated?
- GenScript — Impact of Counter-ion in Peptide on Studies in Different Research Fields
- The Role of Counter-Ions in Peptides — An Overview (PMC)
- USP — Peptide Monographs and General Chapters
- European Medicines Agency
- Janoshik Analytical — Independent Peptide Testing
- Peptigrity — Peptide Shop Reviews and Lab Tests